Akebia Therapeutics (AKBA) Debt to Equity (2011 - 2026)
Akebia Therapeutics (AKBA) debt to equity from Dec 31, 2011 to Mar 31, 2026. The current Akebia Therapeutics (AKBA) debt to equity is 178.56%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Akebia Therapeutics (AKBA)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 147.96% | -288.08% |
| 2024 | -78.67% | -30.63% |
| 2023 | -113.41% | -108.98% |
| 2022 | 1263.48% | N/A |
| 2022 | 1263.48% | +858.69% |
| 2021 | 131.79% | N/A |
| 2021 | 131.79% | +238.60% |
| 2020 | 38.92% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | 19.20% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | 2.36% | N/A |
| 2017 | 0.00% | N/A |
| 2016 | 0.00% | N/A |
| 2015 | 0.00% | N/A |
| 2014 | 0.00% | N/A |
| 2013 | 0.00% | N/A |
| 2012 | 0.00% | N/A |
| 2011 | 0.00% | N/A |
Comparison Akebia Therapeutics (AKBA) debt to equity with competitors
Akebia Therapeutics (AKBA) debt to equity is 178.56%.